Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Oxazepam hemisuccinate
RN: 4700-56-5
UNII: DCE8700INN
InChIKey: UCUOKZUJHTYPJT-UHFFFAOYSA-N

Classification Code

  • Drug / Therapeutic Agent

Molecular Formula

  • C19-H15-Cl-N2-O5

Molecular Weight

  • 386.7895
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Oxazepam hemisuccinate

Synonyms

  • (+-)-Oxazepam hemisuccinate
  • (+-)-Oxazepam succinate
  • (RS)-Oxazepam H
  • 7-Chloro-1,3-dihydro-3-hemisuccinyloxy-2H-1,4-benzodiazepin-2-one
  • BRN 0769233
  • Butanedioic acid, mono(7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl) ester
  • EINECS 225-175-2
  • Empracil
  • Nulans
  • Oxazepam succinate
  • SAS 538
  • UNII-DCE8700INN

Systematic Names

  • (7-Chloro-2,3-dihydro-2-oxo-5-phenyl-1H-benzo-1,4-diazepin-3-yl) hydrogen succinate
  • Butanedioic acid, mono(7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl) ester
  • Succinic acid, monoester with 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one

Registry Numbers

CAS Registry Number

  • 4700-56-5

FDA UNII

  • DCE8700INN

Other Registry Numbers

  • 123632-29-1
  • 24353-21-7
  • 36406-19-6
  • 36434-10-3

Related Registry Number

  • 3693-18-3 (mono-hydrochloride salt)

System Generated Number

  • 0004700565

Structure Descriptors

InChI

1S/C19H15ClN2O5/c20-12-6-7-14-13(10-12)17(11-4-2-1-3-5-11)22-19(18(26)21-14)27-16(25)9-8-15(23)24/h1-7,10,19H,8-9H2,(H,21,26)(H,23,24)

InChIKey

UCUOKZUJHTYPJT-UHFFFAOYSA-N

Smiles

c1ccc(cc1)C2=NC(C(=O)Nc3c2cc(cc3)Cl)OC(=O)CCC(=O)O

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 375mg/kg (375mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION
Farmaco, Edizione Pratica. Vol. 22, Pg. 506, 1967.
mouse LD50 intravenous 285mg/kg (285mg/kg) VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Farmaco, Edizione Pratica. Vol. 22, Pg. 506, 1967.
mouse LD50 oral 1148mg/kg (1148mg/kg)   "Burger's Medicinal Chemistry," 4th ed., Wolff, M.E., ed., New York, John Wiley & Sons, Inc., 1980Vol. 4(3), Pg. 988, 1980.
mouse LD50 oral 1148mg/kg (1148mg/kg) VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Farmaco, Edizione Pratica. Vol. 22, Pg. 506, 1967.